News

What's the difference between a 500-year flood and a 1000-year flood? Trump threatens to impose up to 200% tariff on pharmaceuticals 'very soon' This Is One of the Best Places to Retire in the U.S.
U.S. President Donald Trump said he is planning to announce tariffs on imported semiconductor and pharmaceuticals, saying the rate for medicines could reach 200% but that he would give drugmakers ...
Sources have confirmed to CNBC-TV18 that a formal discussion may take place in the upcoming GST Council meeting, where a ...
JCR Pharmaceuticals has signed a licence agreement with Alexion, AstraZeneca Rare Disease, for its proprietary JUST-AAV capsids.
Scott Vogelsberg explores the biotech space and the changing nature of the relationship between pharma and biotech. As the pharmaceutical industry has struggled to address barren pipelines, the ...
Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...
As biosimilars struggle to live up to their promise of cutting costs and improving access to biologic medicines for U.S. patients, more than 39 advocacy groups are championing recent bipartisan ...
Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.
Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.
HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...
JCR announced that it has entered into a license agreement with Alexion, for JCR’s new, proprietary JUST-AAV capsids to ...
Inspired by Hollywood’s narrative structure, character development and cinematic artistry, pharma brands can reframe their creative potential through a lens of human experience. Wonder More, GSW’s ...